Science ❯Medical Research ❯Clinical Trials

Drug Efficacy

Neurological Disorders Long-acting Treatments Weight Loss Treatments GLP-1 Receptor Agonists Cardiovascular Disease Research HIV Research Preventive Medicine Alzheimer's Research Health Outcomes HIV Treatment Innovations Safety Assessments Public Health

4 ARTICLES

last mo.

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

The CHMP’s positive opinion sets the stage for final EU Commission approval to replace high-global-warming-potential propellant with Honeywell’s lower-carbon alternative throughout AstraZeneca’s regional supply

7 ARTICLES

last mo.

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

7 ARTICLES

5mo ago

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

4 ARTICLES

9mo ago

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

10 ARTICLES

10mo ago

Novo Nordisk Launches Wegovy in France Without Reimbursement

6 ARTICLES

last yr.

New HIV Drug Could Revolutionize Prevention at Just $40 Annually

Drug Efficacy

EU Regulator Recommends AstraZeneca’s Low-Carbon COPD Inhaler

B.C. Panel Confirms End to Brineura Funding for Batten Disease Treatment

FDA Approves Six-Month HIV Prevention Injection Lenacapavir

BC Discontinues Brineura Funding for 9-Year-Old with Batten Disease

NICE Poised to Reject NHS Coverage for Breakthrough Alzheimer’s Drugs

NHS Weight-Loss Jab Prescriptions Near Three Million as Experts Raise Lifelong Use Concerns

Eli Lilly’s Lepodisiran Achieves 94% Reduction in Genetic Heart Disease Risk Factor in Phase 2 Trial

Nurse's Death Linked to NHS-Approved Weight-Loss Drug Mounjaro

Novo Nordisk Launches Wegovy in France Without Reimbursement

New HIV Drug Could Revolutionize Prevention at Just $40 Annually